Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1821837> ?p ?o }
Showing triples 1 to 21 of
21
with 100 triples per page.
- Q1821837 subject Q22230916.
- Q1821837 subject Q7145095.
- Q1821837 subject Q7775055.
- Q1821837 abstract "Inhalable insulin is a powdered form of insulin, delivered with a nebulizer into the lungs where it is absorbed. A 2007 systematic review concluded that the inhaled hexameric insulin Exubera "appears to be as effective, but no better than injected short-acting insulin. The additional cost is so much more that it is unlikely to be cost-effective."Exubera, developed by Inhale Therapeutics (later named Nektar Therapeutics), became the first inhaled insulin product to be marketed in 2006 by Pfizer, but poor sales led Pfizer to withdraw it in 2007. Afrezza, a monomeric inhaled insulin developed by Mannkind, was approved by the FDA in 2014.".
- Q1821837 wikiPageWikiLink Q1504425.
- Q1821837 wikiPageWikiLink Q17114308.
- Q1821837 wikiPageWikiLink Q180865.
- Q1821837 wikiPageWikiLink Q1821837.
- Q1821837 wikiPageWikiLink Q204711.
- Q1821837 wikiPageWikiLink Q206921.
- Q1821837 wikiPageWikiLink Q22230916.
- Q1821837 wikiPageWikiLink Q2281580.
- Q1821837 wikiPageWikiLink Q4727688.
- Q1821837 wikiPageWikiLink Q632240.
- Q1821837 wikiPageWikiLink Q6750663.
- Q1821837 wikiPageWikiLink Q7145095.
- Q1821837 wikiPageWikiLink Q7775055.
- Q1821837 wikiPageWikiLink Q818846.
- Q1821837 wikiPageWikiLink Q918396.
- Q1821837 comment "Inhalable insulin is a powdered form of insulin, delivered with a nebulizer into the lungs where it is absorbed. A 2007 systematic review concluded that the inhaled hexameric insulin Exubera "appears to be as effective, but no better than injected short-acting insulin.".
- Q1821837 label "Inhalable insulin".